https://grail.com/presentations/potential-for-earlier-cancer-diagnosis-to-reduce-cancer-deaths-differences-by-sex-and-race-ethnicity/ 2021-05-17T16:57:55+00:00 https://grail.com/presentations/patient-reported-outcomes-associated-with-a-cancer-screening-a-systematic-review/ 2021-05-17T16:57:32+00:00 https://grail.com/presentations/analytical-performance-of-a-cfdna-based-targeted-methylation-multi-cancer-early-detection-test-for-population-scale-screening/ 2021-04-14T17:51:08+00:00 https://grail.com/presentations/performance-of-a-cell-free-dna-based-multi-cancer-detection-test-as-a-tool-for-diagnostic-resolution-of-symptomatic-cancers/ 2021-04-14T17:50:44+00:00 https://grail.com/presentations/clinical-validation-of-a-targeted-methylation-based-multi-cancer-early-detection-test/ 2021-04-14T17:50:15+00:00 https://grail.com/presentations/many-cell-free-dna-cfdna-mutations-are-derived-from-clonal-hematopoiesis-implications-for-interpretation-of-liquid-biopsy-tests/ 2017-06-03T00:36:41+00:00 https://grail.com/presentations/performance-of-a-high-intensity-508-gene-circulating-tumor-dna-ctdna-assay-in-patients-with-metastatic-breast-lung-and-prostate-cancer/ 2017-06-03T00:35:52+00:00 https://grail.com/presentations/conta-methods-for-detecting-trace-amounts-of-contamination/ 2017-07-24T00:35:24+00:00 https://grail.com/presentations/development-of-cell-free-nucleic-acid-based-tests-for-detection-of-invasive-breast-cancer-the-strive-study/ 2017-12-08T00:34:23+00:00 https://grail.com/presentations/development-of-plasma-cell-free-dna-assays-for-early-cancer-detection-first-insights-from-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-04-17T00:33:57+00:00 https://grail.com/presentations/breast-cancer-cell-free-dna-cfdna-profiles-reflect-underlying-tumor-biology-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-06-02T00:33:29+00:00 https://grail.com/presentations/development-of-a-comprehensive-cell-free-dna-cfdna-assay-for-early-detection-of-multiple-tumor-types-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-06-04T00:32:55+00:00 https://grail.com/presentations/genome-wide-sequencing-for-early-stage-lung-cancer-detection-from-plasma-cell-free-dna-cfdna-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-06-04T00:32:28+00:00 https://grail.com/presentations/prevalence-of-clonal-hematopoiesis-of-indeterminate-potential-chip-measured-by-an-ultra-sensitive-sequencing-assay-exploratory-analysis-of-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-06-05T00:32:01+00:00 https://grail.com/presentations/plasma-cell-free-dna-cfdna-assays-for-early-multi-cancer-detection-the-circulating-cell-free-genome-atlas-ccga-study/ 2018-10-19T00:31:28+00:00 https://grail.com/presentations/plasma-based-molecular-testing-for-early-detection-of-lung-cancer/ 2018-11-08T00:31:01+00:00 https://grail.com/presentations/cell-free-dna-cfdna-fragment-length-patterns-of-tumor-and-blood-derived-variants-in-participants-with-and-without-cancer/ 2019-04-02T00:30:34+00:00 https://grail.com/presentations/detection-of-tissue-specific-rna-in-the-plasma-of-cancer-patients-a-circulating-cell-free-genome-atlas-ccga-substudy/ 2019-05-09T00:30:10+00:00 https://grail.com/presentations/tumor-shedding-into-cell-free-dna-cfdna-is-associated-with-high-mortality-cancers/ 2019-05-10T00:29:25+00:00 https://grail.com/presentations/modeling-reductions-in-absolute-cancer-mortality-from-diagnosing-cancers-before-metastasis-2006-2015/ 2019-05-22T00:28:58+00:00 https://grail.com/presentations/the-circulating-cell-free-genome-atlas-ccga-study-size-selection-of-cell-free-dna-cfdna-fragments/ 2019-06-01T00:28:25+00:00 https://grail.com/presentations/genome-wide-cell-free-dna-cfdna-methylation-signatures-and-effect-on-tissue-of-origin-too-performance/ 2019-06-01T00:27:47+00:00 https://grail.com/presentations/the-circulating-cell-free-genome-atlas-ccga-study-follow-up-f-u-on-non-cancer-participants-with-cancer-like-cell-free-dna-signals/ 2019-06-01T00:27:20+00:00 https://grail.com/presentations/prognostic-significance-of-blood-based-cancer-detection-in-plasma-cell-free-dna-cfdna-evaluating-risk-of-overdiagnosis/ 2019-06-03T00:26:38+00:00 https://grail.com/presentations/trial-in-progress-cancer-screening-study-with-or-without-low-dose-lung-ct-to-validate-a-multi-cancer-early-detection-blood-test-summit/ 2019-09-08T00:26:10+00:00 https://grail.com/presentations/oral-presentation-multi-cancer-detection-of-early-stage-cancers-with-simultaneous-tissue-localization-using-a-plasma-cfdna-based-targeted-methylation-assay/ 2019-09-27T00:25:26+00:00 https://grail.com/presentations/simultaneous-multi-cancer-detection-and-tissue-of-origin-too-localization-using-targeted-bisulfite-sequencing-of-plasma-cell-free-dna-cfdna-2/ 2019-10-11T00:25:00+00:00 https://grail.com/presentations/oral-presentation-simultaneous-multi-cancer-detection-and-tissue-of-origin-too-localization-using-targeted-bisulfite-sequencing-of-plasma-cellfree-dna-cfdna/ 2019-10-11T00:24:30+00:00 https://grail.com/presentations/optimized-early-cancer-detection-from-whole-genome-sequencing-of-cell-free-dna/ 2019-10-16T00:24:00+00:00 https://grail.com/presentations/oral-presentation-novel-non-invasive-cell-free-nucleic-acid-based-diagnostic-test-for-liver-fibrosis-in-patients-with-type-ii-diabetes/ 2019-11-10T00:23:30+00:00 https://grail.com/presentations/blood-based-cancer-detection-in-plasma-cell-free-dna-cfdna-evaluating-clinical-and-pathologic-tumor-characteristics-in-participants-with-breast-cancer/ 2019-12-13T00:23:01+00:00 https://grail.com/presentations/oral-presentation-performance-of-a-blood-based-test-for-the-detection-of-multiple-cancer-types/ 2020-01-23T00:22:33+00:00 https://grail.com/presentations/performance-of-a-blood-based-test-for-the-detection-of-multiple-cancer-types/ 2020-01-23T00:21:50+00:00 https://grail.com/presentations/tumor-area-and-microscopic-extent-of-invasion-to-estimate-circulating-tumor-dna-fraction-in-plasma-and-detectability-of-colorectal-cancer-2/ 2020-01-24T00:21:18+00:00 https://grail.com/presentations/prediction-of-cancer-and-tissue-of-origin-in-individuals-with-suspicion-of-cancer-using-a-cell-free-dna-multi-cancer-early-detection-test/ 2020-04-28T00:20:48+00:00 https://grail.com/presentations/the-pathfinder-study-assessment-of-the-implementation-of-an-investigational-multi-cancer-early-detection-test-into-clinical-practice/ 2020-04-28T00:19:57+00:00 https://grail.com/presentations/tumor-area-and-microscopic-extent-of-invasion-to-estimate-circulating-tumor-dna-fraction-in-plasma-and-detectability-of-colorectal-cancer/ 2020-05-05T00:19:27+00:00 https://grail.com/presentations/simultaneous-multi-cancer-detection-and-tissue-of-origin-too-localization-using-targeted-bisulfite-sequencing-of-plasma-cell-free-dna-cfdna/ 2020-05-03T00:18:41+00:00 https://grail.com/presentations/tumor-methylation-patterns-accurately-measure-tumor-fraction-in-cell-free-dna/ 2020-05-29T00:18:05+00:00 https://grail.com/presentations/hpv-driven-cancers-show-distinct-methylation-signatures-in-cell-free-dna-cfdna/ 2026-05-12T17:00:36+00:00 https://grail.com/presentations/classifier-performance-of-a-cfdna-based-multi-cancer-detection-test-on-uncommon-cancer-types/ 2026-05-12T17:00:50+00:00 https://grail.com/presentations/cfdna-methylation-profiling-distinguishes-lineage-specific-hematologic-malignancies/ 2026-05-12T17:01:06+00:00 https://grail.com/presentations/simultaneous-multi-cancer-detection-and-tissue-of-origin-prediction-via-targeted-bisulfite-sequencing-of-plasma-cell-free-dna/ 2020-10-16T20:29:22+00:00